FK143, a novel nonsteroidal inhibitor of steroid 5α-reductase: (1) In vitro effects on human and animal prostatic enzymes
- 1 April 1995
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 52 (4) , 357-363
- https://doi.org/10.1016/0960-0760(94)00187-q
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Benign Prostatic Hyperplasia: Pathogenesis and Medical TherapyJournal of the American Geriatrics Society, 1991
- Inhibitors of steroid 5α-reductase in benign prostatic hyperplasia, male pattern baldness and acneTrends in Pharmacological Sciences, 1989
- Biological Actions of AndrogensEndocrine Reviews, 1987
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984
- Characterization of the Cytosol Androgen Receptor of the Human Prostate*Journal of Clinical Endocrinology & Metabolism, 1983
- The pathogenesis of benign prostatic hyperplasiaThe American Journal of Medicine, 1980
- Steroid 5α-Reductase Deficiency in a 65-Year-Old Male Pseudohermaphrodite: The Natural History, Ultrastructure of the Testes, and Evidence for Inherited Enzyme Heterogeneity*Journal of Clinical Endocrinology & Metabolism, 1980
- Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male PseudohermaphroditismScience, 1974
- Selective Retention of Dihydrotestosterone by Prostatic NucleiNature, 1968
- The Conversion of Testosterone to 5α-Androstan-17β-ol-3-one by Rat Prostate in Vivo and in VitroJournal of Biological Chemistry, 1968